THER
Price:
$0.0001
Market Cap:
$615.15K
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable inform...[Read more]
Industry
Biotechnology
IPO Date
2010-04-01
Stock Exchange
PNK
Ticker
THER
According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.38M. This represents a change of -27.55% compared to the average of 26.75M of the last 4 quarters.
The mean historical Enterprise Value of Theralink Technologies, Inc. over the last ten years is 76.49M. The current 19.38M Enterprise Value has changed 2.43% with respect to the historical average. Over the past ten years (40 quarters), THER's Enterprise Value was at its highest in in the February 2015 quarter at 98.19B. The Enterprise Value was at its lowest in in the September 2020 quarter at -1264772.10.
Average
76.49M
Median
24.43M
Minimum
3.50M
Maximum
295.02M
Discovering the peaks and valleys of Theralink Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 962.67%
Maximum Annual Enterprise Value = 295.02M
Minimum Annual Increase = -97.62%
Minimum Annual Enterprise Value = 3.50M
Year | Enterprise Value | Change |
---|---|---|
2023 | 24.30M | -1.08% |
2022 | 24.57M | -90.86% |
2021 | 268.65M | 962.67% |
2020 | 25.28M | 621.49% |
2019 | 3.50M | -21.30% |
2018 | 4.45M | -34.46% |
2017 | 6.79M | -3.44% |
2016 | 7.04M | -97.62% |
2015 | 295.02M | 180.06% |
2014 | 105.34M | 672.53% |
The current Enterprise Value of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
105.84M
5-year avg
69.26M
10-year avg
76.49M
Theralink Technologies, Inc.’s Enterprise Value is less than Adhera Therapeutics, Inc. (0), greater than GB Sciences, Inc. (10.81M), greater than SciSparc Ltd. (1.75M), greater than Creative Medical Technology Holdings, Inc. (540.60K), greater than Regen BioPharma, Inc. (-1810684.00), greater than Enzolytics Inc. (1.53M), less than Sonnet BioTherapeutics Holdings, Inc. (205.79M), greater than Inhibikase Therapeutics, Inc. (-907921.00), less than Sio Gene Therapies Inc. (154.45M), greater than Kaleido Biosciences, Inc. (-61213000.00), greater than Tempest Therapeutics, Inc. (4.26K), less than Lexaria Bioscience Corp. (35.14M), less than Navidea Biopharmaceuticals, Inc. (0), less than ZyVersa Therapeutics, Inc. (28.16M), greater than Biodexa Pharmaceuticals Plc (-2504975.00), greater than Oncorus, Inc. (2.53M), greater than null (-2820215.62), less than null (42.71M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $17.33K | |
10.81M | $407.00 | |
1.75M | $2.54M | |
540.60K | $4.45M | |
-1810684.00 | $851.41K | |
1.53M | $4.79M | |
205.79M | $2.50M | |
-907921.00 | $155.21M | |
154.45M | $0 | |
-61213000.00 | $4.26K | |
4.26K | $39.52M | |
35.14M | $36.48M | |
0 | $100.08K | |
28.16M | $2.65M | |
-2504975.00 | $2.32M | |
2.53M | $0 | |
-2820215.62 | $0 | |
42.71M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Theralink Technologies, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Theralink Technologies, Inc. (THER)?
What is the 3-year average Enterprise Value for Theralink Technologies, Inc. (THER)?
What is the 5-year average Enterprise Value for Theralink Technologies, Inc. (THER)?
How does the current Enterprise Value for Theralink Technologies, Inc. (THER) compare to its historical average?